Walmart says it’s using customer data to see if people who fill Wegovy or Ozempic prescriptions are buying less food, raising privacy questions.
Last week, Walmart made headlines with a claim that new weight loss drugs might be making people buy less food. Walmart US CEO John Furner told Bloomberg that people taking Wegovy, Ozempic, and similar drugs showed a “slight change” in their purchasing habits: “just less units, slightly less calories.” How does Walmart know this? Because, Bloomberg indicates, it can compare people’s prescription history against their food shopping patterns.
But per Bloomberg, Walmart promises its data is anonymized, or stripped of identifying details that could be tied back to specific patients. Unfortunately, the idea that huge, complex datasets can be meaningfully “anonymous” is largely a polite fiction. “Even anonymized prescription details can reveal a lot about individuals,” says Sklar. “Details like medication, dosage, timing, prescriber, pharmacy, etc. can be very unique to an individual, which makes it easier to re-identify someone.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
What to Know About Hitting a Weight Loss Plateau While on Ozempic or WegovyIf you take Ozempic or Wegovy, will you keep losing weight or hit a plateau? Even though a plateau can be inevitable, staying on the drugs can help you maintain your weight loss.
続きを読む »
Exclusive: Catalent's Indiana plant to make Novo's Wegovy weight-loss drug-sourcesCatalent's (CTLT.N) plant in Bloomington, Indiana, will fill injection pens for Novo Nordisk's (NOVOb.CO) weight-loss drug Wegovy as part of the two companies' expanded supply agreement, two sources familiar with the matter told Reuters.
続きを読む »
Exclusive: Novo Nordisk hires private U.S. firm to handle some Wegovy pen assembly -sourceNovo Nordisk (NOVOb.CO) has hired U.S. private contract manufacturer PCI Pharma Services to handle assembly and packaging of Wegovy, a source familiar with the matter said, as it races to boost output of the weight-loss drug to meet demand.
続きを読む »
Forget TikTok claims: ‘Nature’s Ozempic’ is no such thing, experts sayUsing berberine as a supplement has become so trendy, in fact, that it has been dubbed “Nature’s Ozempic” by social media users.
続きを読む »
The big AI and robotics concept that has attracted both Walmart and SoftbankSymbotic is an AI-powered warehouse technology that has deals with Walmart, Target and Albertsons. Its stock is up a lot, and Walmart is a big shareholder.
続きを読む »